RN486

RN486 Basic information
Biological activity In vitro In vivo
Product Name:RN486
Synonyms:RN486;6-cyclopropyl-8-fluoro-2-(2-(hydroxyMethyl)-3-(1-Methyl-5-((5-(4-Methylpiperazin-1-yl)pyridin-2-yl)aMiNA)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)isoquiNAlin-1(2H)-one;6-cyclopropyl-8-fluoro-2-(2-(hydroxyMethyl)-3-(1-Methyl-5-(5-(4-Methylpiperazin-1-yl)pyridin-2-ylaMino)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)isoquinolin-1(2H)-one;CS-689;RN486; RN-486; RN 486;RN486/RN-486;RN468;6-Cyclopropyl-2-[3-[1,6-dihydro-1-methyl-5-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-8-fluoro-1(2H)-isoquinolinone
CAS:1242156-23-5
MF:C35H35FN6O3
MW:606.69
EINECS:200-110-4
Product Categories:Inhibitors
Mol File:1242156-23-5.mol
RN486 Structure
RN486 Chemical Properties
Boiling point 868.6±65.0 °C(Predicted)
density 1.378±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility ≥30.35 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH
form solid
pka13.95±0.10(Predicted)
CAS DataBase Reference1242156-23-5
Safety Information
MSDS Information
RN486 Usage And Synthesis
Biological activityRN486 is an effective BTK inhibitor with an IC50 of 4 nM.
In vitroRN486 not only potently and selectively inhibits the Btk enzyme, but also displays functional activities in human cell-based assays in multiple cell types, blocking Fcε receptor cross-linking-induced degranulation in mast cells (IC50 = 2.9 nM), Fcγ receptor engagement-mediated tumor necrosis factor α production in monocytes (IC50 = 7.0 nM), and B cell antigen receptor-induced expression of an activation marker, CD69, in B cells in whole blood (IC50 = 21.0 nM). RN486 is able to block the signaling of BCR as demonstrated by a marked inhibition of phosphorylation of both Btk and PLCγ2 in B cells. RN486 displays a selective B cell inhibitory profile in BioMAP Systems.
In vivoRN486 displays similar functional activities in rodent models, effectively preventing type I and type III hypersensitivity responses. More importantly, RN486 produces robust anti-inflammatory and bone-protective effects in mouse CIA and rat adjuvant-induced arthritis (AIA) models. In the AIA model, RN486 inhibits both joint and systemic inflammation either alone or in combination with methotrexate, reducing both paw swelling and inflammatory markers in the blood.
UsesRN 486 is a Bruton’s tyrosine kinase (Btk) inhibitor, blocking receptor cross-linking-induced degranulation in mast cells. May be used in the prevention of arthritis and other autoimmune diseases.
RN486 Preparation Products And Raw materials
R-406 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide Ibrutinib RKI1447 RN-1 (hydrochloride)

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.